Patients who undergo stepwise escalation often reach treatment failure more often.” He noted that combination therapy may be ...

Researchers conducted a phase 3 trial to compare the efficacy and safety of synthetic semaglutide with Ozempic® for glycemic ...

GLP-1 receptor agonists are reshaping care for type 2 diabetes, obesity, chronic kidney disease, and obstructive sleep apnea, ...

Patients with type 2 diabetes (T2D) at an elevated risk for kidney failure may stand to gain the most renal benefit with intensive glycemic control, but they also face the highest overall risk for ...

The PIONEER TEENS trial compared oral semaglutide at maximum tolerated doses with placebo in adolescents aged 10 to 17 years with T2D.

After the initiation of an AID system, glycemic control improved and the effect persisted throughout the study period. (HealthDay News) — Initiation of an automated insulin delivery (AID) system ...

Recent updates to the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) guidelines have focused on the need for more intensive therapy in patients with type 2 ...

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research ...

Relaxed glycemic control targets were associated with an increased risk for skin, bone, and soft tissue infections among older adults with type 2 diabetes. Older adults with type 2 diabetes and ...

Diabetes prevalence in U.S. adults over the past decade has remained stable, with a small non-significant increase. HbA1c and rates of glycemic control significantly worsened from 2017-2020 to ...

Trail mix with nuts, seeds, and unsweetened dried fruit can help support stable blood sugar due to its protein, fiber, and ...